Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the landmark TOGETHER-PsO open-label Phase 3b ...
Concomitant ixekizumab and tirzepatide significantly improved skin clearance and weight reduction in adults with moderate to severe plaque psoriasis.
After days of selling pressure, positive sentiments returned at the Pakistan Stock Exchange (PSX), with the benchmark KSE-100 ...
Eli Lilly (LLY) stock is in focus as Zepbound succeeds in a late-stage trial for patients with plaque psoriasis. Read more ...
Trading kicked off at the Pakistan Stock Exchange (PSX) on a positive note amid days of selling pressure, with the benchmark ...
Bears tightened their grip on the Pakistan Stock Exchange (PSX) on Tuesday as foreign corporate selling continued, sending ...
With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. | Six weeks after Eli Lilly revealed the success of phase 3b ...
The Express Tribune on MSN
PSX extends losses as KSE-100 closes 1,300 points lower
The Pakistan Stock Exchange (PSX) extended its downturn on Tuesday, with the benchmark KSE-100 index falling 1,303.52 points to settle at 173,150.42, as persistent foreign corporate selling ...
6hon MSN
Eli Lilly's landmark trial shows major psoriasis-obesity breakthrough with Taltz-Zepbound combo
Eli Lilly and Co. LLY on Wednesday shared topline results from the landmark TOGETHER-PsO open-label Phase 3b trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) ...
According to Sowore, Kuti is seeking an ex-parte injunction to restrain him from publicly stating that she is the mistress of the IGP. He said that the promotion itself was irregular and part of a ...
Join our free webinar for a quick tour around ch-aviation with an introduction to its Business Aviation data & news and best practices for a flying start.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results